Limpar, Alvin James .

HRN: 22-59-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2023
CEFTRIAXONE 1G (VIAL)
02/16/2023
02/23/2023
IV
1 G
Q24
PCAP-C; R/O PTB
Waiting Final Action 
02/16/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/16/2023
02/23/2023
IV
1 G
Q24
PCAP-C ; R/O PTB

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: